Press Release

Technologies Enable Discoveries in Biomedical Research and Drug Development

WHAT:

PerkinElmer, Inc. , a global leader focused on improving the health and safety of people and the environment, today announced that it will highlight several of its informatics offerings at the 2015 Bio-IT World Conference & Expo. This annual event unites more than 3,000 life science, pharmaceutical, clinical, healthcare, and IT professionals from over 32 countries to showcase IT and informatics applications for biomedical research and drug discovery.

“We are pleased to demonstrate how our innovative informatics technologies leverage and transform research and clinical study data into actionable insights to advance new developments in molecular medicine,” said Karen Madden, President, Informatics, PerkinElmer. “Our solutions help customers visualize, analyze and integrate their data, contributing to breakthroughs in translational medicine research.”

WHEN:

April 21-23, 2015

WHERE:

Seaport World Trade Center, Boston (Booth #210)

ON DISPLAY:

PerkinElmer will feature and provide demos of the following informatics products at its booth:

TIBCO Spotfire® Platform: a collaborative interface assimilating data such as chemical structures, text, numbers, images, chemical properties and biological assays from multiple sources. It helps scientists perform complex analyses and develop easy-to-use visual dashboards. Researchers can create enhanced data visualizations quickly and efficiently from the data of one or multiple instruments.

• • For clinical research and development applications, the TIBCO Spotfire® software platform enables clinical researchers to build robust analytic solutions using data from multiple, disparate clinical development systems, without delays or strain on biostatistics and IT resources.
• • For translational medicine applications, the TIBCO Spotfire® software platform enables the integration, analysis and visualization of biological and clinical data to transform traditional research into translational medicine.

OmicsOffice® software: OmicsOffice® software: a solution to help scientists enhance functional and biological discovery from genomics studies, offering workflows and tools for qPCR, microarray and NGS data analysis, integration and validation.

High Content Profiler™ software: a single, automated platform to perform the entire screening analysis, helping scientists to overcome data analysis challenges and move confidently to the next phase of gene targeting or drug discovery.

Lead Discovery software: this application, powered by TIBCO® , helps chemists visualize and explore complex data and structure-activity relationships through chemical structure viewing and filtering, R-group decomposition, clustering by chemical structure, chemical property calculations, and substructure searching.

PRESENTATION:

On Wednesday, April 22 at noon, Jens Hoefkens, Ph.D., Director, Research and Strategic Marketing Manager for PerkinElmer will deliver the presentation “Integrating Data is the Key to Translational Research and the Future of Personalized Medicine.”

Hoefkens will discuss how PerkinElmer’s tools, can generate, analyze, visualize and store data to support advances in translational medicine research.

ABOUT PERKINELMER:

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2.2 billion in 2014, has about 7,700 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com

Media Contact:
Sutton Resler
sresler@apcoworldwide.com
202-778-1037